Caption Management’s AstraZeneca AZN Stock Holding History

Caption Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.8M	Buy	60,000 +30,000	+100%	+$5.78M	0.07%	294
2025 Q4	$5.52M	Buy	+30,000	New	+$5.26M	0.04%	489
2023 Q4	–	Sell	-70,000	Closed	-$9.48M	–	1333
2023 Q3	$9.48M	Sell	70,000 -124,450	-64%	-$17M	0.15%	167
2023 Q2	$27.8M	Buy	194,450 +74,450	+62%	+$11M	0.49%	31
2023 Q1	$16.7M	Sell	120,000 -25,000	-17%	-$3.36M	0.32%	70
2022 Q4	$19.7M	Hold	145,000	–	–	0.31%	67
2022 Q3	$15.9M	Buy	145,000 +97,500	+205%	+$12.4M	0.22%	90
2022 Q2	$6.28M	Buy	47,500 +45,000	+1,800%	+$5.9M	0.09%	284
2022 Q1	$331K	Sell	2,500 -172,500	-99%	-$20.7M	﹤0.01%	1202
2021 Q4	$20.4M	Buy	175,000 +100,000	+133%	+$11.8M	0.23%	91
2021 Q3	$9.01M	Hold	75,000	–	–	0.1%	257
2021 Q2	$8.99M	Sell	75,000 -1,550	-2%	-$170K	0.12%	221
2021 Q1	$7.61M	Buy	76,550 +50,000	+188%	+$5.03M	0.16%	158
2020 Q4	$2.65M	Buy	+26,550	New	+$2.81M	0.06%	370
2020 Q3	–	Sell	-25,000	Closed	-$2.64M	–	1032
2020 Q2	$2.64M	Buy	+25,000	New	+$2.58M	0.09%	311

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Caption Management's AZN Position: Q1 2026 in Review

Caption Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 88,950 shares — an estimated $17.2M sold.

Caption Management first reported a position in AZN in Q2 2020 and held it in 17 quarters. The position peaked at $16.4M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Caption Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Caption Management sold 88,950 AstraZeneca shares in Q1 2026, an estimated $17.2M.
Caption Management first reported a position in AstraZeneca in Q2 2020 and held it in 17 quarters.
Caption Management's AstraZeneca position peaked at $16.4M in Q4 2025.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.